Opus Genetics reports positive pediatric data from LCA5 gene therapy study
Opus Genetics, Inc. released positive data from a pediatric cohort in an ongoing phase 1/2 clinical study evaluating OPGx-LCA5, an...
pediatric
Opus Genetics reports 1-month pediatric results in gene therapy for inherited retinal disease
(Image Credit: AdobeStock/Artinun)Opus Genetics announced the 1-month open-label phase 1/2 results from the first pediatric patients treated with its investigational...
